Intended for UK HCPs and ORDMs only.

Facilitating
treatment adherence

Oral solid dose formats do not suit all patients

  • Many elderly patients have issues about taking tablets

Proportion of patients with difficulty swallowing

Proportion of patients with difficulty swallowing

Adapted from 1,2,3,4,5

  • Difficulty swallowing is believed to affect up to 50% of the elderly1 and one study suggested 68% of care home residents were affected2
  • Dysphagia affects over 50% of survivors immediately post-stroke and up to 13% remain dysphagic after 6 months3
  • In one study, dysphagia was identified in up to 75% of people with Alzheimer’s disease4
  • Dysphagia has been shown to be present in over 50% of patients treated for head and neck cancer5

  • Paediatric patients may also experience difficulties

  • There is no set age at which children can safely swallow tablets6
  • For younger patients, liquids are the dosage form of choice6 and palatability is key7

  • Dose titration may be less flexible with solid oral dose medication

  • Atorvastatin dosage is individualised and up-titrated from 10mg OD until desired lipid levels are achieved8
  • Muscular aches and pains are a common side effect and dosage may need to be adjusted to control them9,10
Rosemont Atorvastatin 4mg/ml Oral Suspension - Lipid Lowering Treatment.

Atorvastatin 4mg/ml Oral Suspension

The first licensed liquid atorvastatin